Table 3. The Achievement and Quality Measures and In-hospital Outcomes.
| ED admission | Transfer-in | Overall | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||||
| CSCs | PSCs | StdDiff (%) | p | CSCs | PSCs | StdDiff (%) | p | CSC | PSC | StdDiff (%) | p | |
| Defect-free Care Measure (%) | 94.2 | 93.8 | -1.62 | <.0001 | 95.5 | 95.2 | -1.83 | .0026 | 94.6 | 94.0 | -2.66 | <.0001 |
|
| ||||||||||||
| Early Antithrombotics (%) | 97.1 | 97.7 | 3.38 | <.0001 | 96.4 | 97.1 | 3.75 | <.0001 | 97.0 | 97.6 | 4.03 | <.0001 |
|
| ||||||||||||
| Antithrombotics (%) | 98.9 | 99.1 | 1.68 | <.0001 | 99.3 | 99.2 | -0.32 | .6174 | 99.0 | 99.1 | 0.87 | .0041 |
|
| ||||||||||||
| Anticoagulation for Atrial Fibrillation (%) | 97.0 | 96.2 | -4.71 | <.0001 | 97.3 | 97.0 | -2.12 | .1844 | 97.1 | 96.3 | -4.75 | <.0001 |
|
| ||||||||||||
| DVT Prophylaxis (%) | 98.9 | 98.8 | -1.28 | .0007 | 99.2 | 99.1 | -0.59 | .3598 | 99.0 | 98.8 | -1.67 | <.0001 |
|
| ||||||||||||
| LDL 100 or Statin (%) | 98.1 | 97.7 | -2.29 | <.0001 | 98.6 | 98.2 | -3.15 | <.0001 | 98.2 | 97.8 | -3.03 | <.0001 |
|
| ||||||||||||
| Smoking Cessation (%) | 98.0 | 97.5 | -3.33 | <.0001 | 98.6 | 97.4 | -8.41 | <.0001 | 98.2 | 97.5 | -4.88 | <.0001 |
|
| ||||||||||||
| Dysphagia Screen (%) | 86.0 | 86.5 | 1.45 | <.0001 | 90.3 | 87.1 | -9.92 | <.0001 | 87.2 | 86.6 | -1.97 | <.0001 |
|
| ||||||||||||
| Stroke Education (%) | 94.8 | 95.7 | 3.97 | <.0001 | 96.6 | 95.8 | -4.05 | <.0001 | 95.3 | 95.7 | 1.83 | <.0001 |
|
| ||||||||||||
| Rehabilitation Considered (%) | 98.6 | 98.6 | 0.44 | .2119 | 99.1 | 99.0 | -0.48 | .4579 | 98.7 | 98.7 | -0.43 | .1568 |
|
| ||||||||||||
| LDL Measured (%) | 93.2 | 92.7 | -2.19 | <.0001 | 94.5 | 92.6 | -7.75 | <.0001 | 93.6 | 92.7 | -3.73 | <.0001 |
|
| ||||||||||||
| Intensive Statin Therapy (%) | 58.9 | 44.7 | -28.80 | <.0001 | 69.2 | 53.5 | -32.66 | <.0001 | 62.0 | 45.8 | -33.05 | <.0001 |
|
| ||||||||||||
| NIHSS Reported (%) | 88.2 | 84.2 | -11.47 | <.0001 | 90.5 | 80.3 | -29.28 | <.0001 | 88.9 | 83.7 | -15.03 | <.0001 |
|
| ||||||||||||
| IV tPA Rate (%) | 14.3 | 10.3 | -12.38 | <.0001 | 1.4 | 1.6 | 1.32 | .0227 | 10.4 | 9.2 | -4.05 | <.0001 |
| IV tPA 3 hr/Arrive 2 hr (%) | 93.6 | 89.4 | -14.94 | <.0001 | 86.2 | 84.0 | -6.06 | .4630 | 93.4 | 89.4 | -14.61 | <.0001 |
| IV tPA 4.5 hr /Arrive 3.5 hr (%) | 84.9 | 73.7 | -27.85 | <.0001 | 62.1 | 57.9 | -8.59 | .0497 | 83.8 | 73.4 | -25.77 | <.0001 |
|
| ||||||||||||
| Door to IV tPA ≤60 minutes (%) | 79.7 | 65.1 | -33.12 | <.0001 | 78.1 | 58.6 | -42.56 | .0470 | 79.7 | 65.0 | -33.14 | <.0001 |
| Door to IV tPA ≤45 minutes (%) | 45.9 | 30.2 | -32.81 | <.0001 | 37.5 | 29.3 | -17.28 | 0.386 | 45.9 | 30.2 | -32.77 | <.0001 |
| Door to IV tPA ≤30 minutes (%) | 14.5 | 7.5 | -22.33 | <.0001 | 9.4 | 5.0 | -16.57 | 0.376 | 14.5 | 7.5 | -22.32 | <.0001 |
| Door to IV tPA Time (minutes), Median (IQR) | 52 (39, 70) | 61 (47, 83) | 26.56 | <.0001 | 44 (31, 61) | 53 (36, 73) | 10.95 | <.0001 | 52 (39, 70) | 60 (47,83) | 25.72 | <.0001 |
|
| ||||||||||||
| Thrombolytic Complications (%) | 4.4 | 4.7 | 1.57 | .0708 | 7.3 | 6.7 | -2.39 | .2701 | 5.0 | 4.8 | -0.63 | .4169 |
|
| ||||||||||||
| EVT Rate (%) | 4.1 | 1.0 | -18.06 | <.0001 | 8.5 | 4.3 | -16.12 | <.0001 | 5.5 | 1.4 | -20.55 | <.0001 |
| Door to EVT Time (minutes), Median (IQR) | 145 (105,192) | 152 (112,215) | 11.29 | <.0001 | 85 (49,138) | 85 (53,141) | 5.67 | .0806 | 119 (75,174) | 132 (85,195) | 12.32 | <.0001 |
|
| ||||||||||||
| In-hospital Mortality (%) | 4.6 | 3.8 | -3.56 | <.0001 | 7.7 | 6.8 | -3.61 | <.0001 | 5.5 | 4.2 | -6.13 | <.0001 |
|
| ||||||||||||
| Length of Stay>4 Days (%) | 40.8 | 37.6 | -7.39 | <.0001 | -- | -- | -- | 40.8 | 37.6 | -8.24 | <.0001 | |
|
| ||||||||||||
| Ambulatory at Discharge (%) | 45.3 | 43.5 | -3.72 | <.0001 | 40.1 | 38.9 | -2.33 | <.0001 | 43.7 | 42.9 | -1.63 | <.0001 |
|
| ||||||||||||
| Discharge Home (%) | 51.1 | 51.3 | 1.15 | .2906 | 45.4 | 47.4 | 4.86 | <.0001 | 49.4 | 50.8 | 4.12 | <.0001 |
Abbreviations: StdDiff, Standardized Difference; DVT, deep vein thrombosis; LDL, low density lipoprotein; NIHSS, National Institute of Health stroke scale; IV tPA; intravenous tissue plasminogen activator; IQR, interquartile range; EVT, endovascular thrombectomy.
Standardized difference greater than 10% or less than -10% was considered imbalance